ExpansionOpportunity Potential for international distribution expansion, notably leveraging past Japan Lifeline partnership to broaden presence in Asia and explore additional strategic distributors in Europe and the Middle East to scale market coverage for radiation shielding solutions.

Strategic Litigation Ongoing patent litigation activity suggests a need for proactive relationship management with key customers to address potential supply interruptions, while highlighting Rampart as a defensible, innovative provider of lead-free radiation protection.

ClinicalAdvantage Unique selling proposition centered on non-lead shielding and comprehensive team protection positions Rampart to target high-volume interventional suites and cardiology centers seeking safer, more comfortable workflow with maintained procedural efficiency.

PartnershipPotential Existing distributor collaboration with Japan Lifeline indicates a replicable channel strategy; pursue multi-region partnerships, OEM opportunities, and hospital group contracts to accelerate adoption across radiology, interventional, and orthopedic departments.

FinancialReadiness Revenue scale and $20M funding signal a growth-ready organization; target mid-to-large hospitals and health systems with capital expenditure plans for radiation protection upgrades and staff safety initiatives.